{
  "num_tested_probands": [
    3,
    6,
    32
  ],
  "num_positive_het_probands": [
    1,
    1,
    0
  ],
  "positive_phenotypes": [
    "US",
    "prolonged duration of action of succinylcholine",
    []
  ],
  "num_compound_or_double_hets": [
    0,
    2,
    1
  ],
  "explanation": {
    "num_tested_probands": [
      "The report mentions that the probands of three unrelated families were referred to DCRU because of prolonged duration of action of succinylcholine. The biochemical tests indicated that two of the patients were homozygous for a silent variant and one was heterozygous for the atypical and a silent variant.",
      "The proband in family 1 (Fig. 1, patient 1\u20132) had the genotype BCHE*115D*I3E4-14C/BCHE*FS126 and displayed prolonged duration of action of succinylcholine.",
      [
        "Kalow W, Lindsay HA. A comparison of optical and manometric methods for the assay of human serum cholinesterase.",
        "Kalow W, Genest K. A method for the detection of atypical forms of human serum cholinesterase. Determination of dibucaine numbers.",
        "Harris H,Whittaker M. Differential inhibition of human serum cholinesterase with fluoride: recognition of two new phenotypes.",
        "Hanel HK, Viby-Mogensen J. The inhibition of serum cholinesterase by urea.",
        "Liddell J, Newman GE, Brown DF. A pseudocholinesterase variant in human tissues.",
        "Gatke MR, Ostergaard D, Bundgaard JR, Varin F, Viby-Mogensen J. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene-Genotyping by sequencing.",
        "Primo-Parmo SL, Lightstone H, La Du BN. Characterization of an unstable variant (BChE115D) of human butyrylcholinesterase.",
        "Primo-Parmo SL, Bartels CF, Wiersema B, van der Spek AF, Innis JW, La Du BN. Characterization of 12 silent alleles of the human butyrylcholinesterase (BCHE) gene.",
        "Ostergaard D, Jensen FS, Skovgaard LT, Viby-Mogensen J. Dose-response relationship for mivacurium in patients with phenotypically abnormal plasma cholinesterase activity.",
        "Jensen FS, Bartels CF, La Du BN. Structural basis of the butyrylcholinesterase H-variant segregating in two Danish families.",
        "Saxena A, Redman AM, Jiang X, Lockridge O, Doctor BP. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.",
        "Masson P, Xie W, Froment MT, Lockridge O. Effects of mutations of active site residues and amino acids interacting with the Omega loop on substrate activation of butyrylcholinesterase.",
        "Xie W, Altamirano CV, Bartels CF, Speirs RJ, Cashman JR, Lockridge O. An improved cocaine hydrolase: the A328Y mutant of human butyryl-cholinesterase is 4-fold more efficient.",
        "Duysen EG, Stribley JA, Fry DL, Hinrichs SH, Lockridge O. Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse."
      ]
    ],
    "num_positive_het_probands": [
      "The report states that the proband in family 2 was not sequenced, but a relative was heterozygous for BCHE*FS126. This indicates that there is only one positive heterozygous proband mentioned in the report.",
      "One patient with a low BChE activity was genotyped as heterozygous for BCHE*FS126 (Table 1, patient 2\u20133).",
      "Gatke MR, Ostergaard D, Bundgaard JR, Varin F, Viby-Mogensen J. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene-Genotyping by sequencing."
    ],
    "positive_phenotypes": [
      "The report mentions that the proband in family 3 was heterozygous for BCHE*I3E4-14C, which corresponds to a phenotype of US (unusual short duration).",
      "The proband in family 3 (Table 1, patient 3) had a prolonged duration of action of succinylcholine of 90 min.",
      "phenotypically abnormal plasma cholinesterase activity"
    ],
    "num_compound_or_double_hets": [
      "There is no mention of compound or double heterozygotes in the report.",
      "Patient 3 was compound heterozygous for BCHE*328D and BCHE*I3E4-14C.",
      "Gatke MR, Ostergaard D, Bundgaard JR, Varin F, Viby-Mogensen J. Response to mivacurium in a patient compound heterozygous for a novel and a known silent mutation in the butyrylcholinesterase gene-Genotyping by sequencing."
    ],
    "explanation": [
      "The report does not provide information on the number of probands tested. However, it mentions that the probands were referred to DCRU because of prolonged duration of action of succinylcholine."
    ]
  }
}